Drug Availability Update

Further to DrugAlert Volume 396, HPS Pharmacies wish to give notice that Pfizer Australia is continuing to experience a supply interruption for DBL Heparin Sodium as follows:

Product ARTG Current Status
DBL Heparin Sodium 5000 IU/5mL 49232 Late August 2018
DBL Heparinised Saline 50 IU/5mL 66684 Mid-October 2018
DBL Heparin Sodium 5000 IU/0.2mL 16349 Late September 2018
DBL Heparin Sodium 5000 IU/1mL 12881 Currently in stock

 

This supply interruption is due to delays in securing adequate manufacturing capacity in response to increased market demand. There are no safety concerns with these products.

Internationally registered brands of Heparinised Saline 50 IU/5mL and Heparin Sodium 5000 IU/5mL have been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Your HPS Pharmacies Clinical Pharmacist can provide advice on other available alternatives.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmaciesor Pfizer Australia on 1800 999 543.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates